Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S M Bakhtiar UL Islam"'
Autor:
Tasbir Amin BSc, Amana Hossain BSc, Nusrat Jerin BSc, Imteaz Mahmud MBBS, Md Ahasanur Rahman PhD, SM Rafiqul Islam PhD, S M Bakhtiar UL Islam PhD
Publikováno v:
Cancer Control, Vol 31 (2024)
Glioblastoma is an aggressive primary brain tumor that poses many therapeutic difficulties because of the high rate of proliferation, genetic variability, and its immunosuppressive microenvironment. The theory of cancer immunoediting, which includes
Externí odkaz:
https://doaj.org/article/025bf16b8fc74e8c994d2eafbaef67de
Autor:
Tasbir Amin, Nusrat Jerin, Amana Hossain, Sadaf Saaz Siddiqi, S M Bakhtiar UL Islam, Shahjada Selim
Publikováno v:
Journal of Advanced Biotechnology and Experimental Therapeutics, Vol 7, Iss 3, Pp 530-545 (2024)
The alarmingly high global prevalence of Type 2 Diabetes Mellitus (T2DM) has made novel treatment strategies imperative. One major contributing factor to the onset of T2DM is mitochondrial dysfunction, which deteriorates cellular health, interferes w
Externí odkaz:
https://doaj.org/article/53010e2cc0054ef6a66734f588db3d94
Autor:
Euna Cho1,2, S. M. Bakhtiar Ul Islam1,3, Fen Jiang1,4, Ju-Eun Park1, Bora Lee1, Nam Deuk Kim2, Tae-Ho Hwang1 thhwang@pusan.ac.kr
Publikováno v:
Cancer Research & Treatment. Jan2020, Vol. 52 Issue 1, p309-319. 11p.
Autor:
Ju-Eun Park, Euna Cho, Nam Deuk Kim, Tae-Ho Hwang, Bora Lee, S. M. Bakhtiar Ul Islam, Fen Jiang
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PURPOSE The purpose of this study was to assess characteristics of SJ-815, a novel oncolytic vaccinia virus lacking a functional thymidine kinase-encoding TK gene, and instead, having two human transgenes: the IFNB1 that encodes interferon β1, and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9840dbfd818e819062487a1abe07deb7
https://doi.org/10.4143/crt.2019.161
https://doi.org/10.4143/crt.2019.161
Publikováno v:
Cancers
Cancers, Vol 12, Iss 1, p 228 (2020)
Volume 12
Issue 1
Cancers, Vol 12, Iss 1, p 228 (2020)
Volume 12
Issue 1
Oncolytic viruses are a promising class of anti-tumor agents
however, concerns regarding uncontrolled viral replication have led to the development of a replication-controllable oncolytic vaccinia virus (OVV). The engineering involves replacing
however, concerns regarding uncontrolled viral replication have led to the development of a replication-controllable oncolytic vaccinia virus (OVV). The engineering involves replacing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23d0fb2d48dcd3681e1d4c16bf48656
http://europepmc.org/articles/PMC7016767
http://europepmc.org/articles/PMC7016767
Autor:
Hyunjung Jang, Soon Cheol Ahn, Daniel Ngabire, Euna Cho, Young Mi Hong, Jessye Jin Joo Hale, Mefotse saha Cyrelle Ornella, Tae-Ho Hwang, Eung-Kyun Kim, Mong Cho, Cy Hyun Kim, S. M. Bakhtiar Ul Islam
Publikováno v:
Biomedicines
Volume 8
Issue 10
Volume 8
Issue 10
Viral replication of thymidine kinase deleted (tk-) vaccinia virus (VV) is attenuated in resting normal cells, enabling cancer selectivity, however, replication potency of VV-tk- appears to be diminished in cancer cells. Previously, we found that wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba6f7698318e06be606283dfb0169da
https://doi.org/10.3390/biomedicines8100426
https://doi.org/10.3390/biomedicines8100426
Publikováno v:
Cellular signalling. 27(6)
We previously showed that an increase of cellular Bcl-xL mediates acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and knockdown of Bcl-xL expression greatly sensitized TRAIL-induced cytotoxicity. Here, we show t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723058414489b698013b1966f852ee7e
https://pubmed.ncbi.nlm.nih.gov/25748050
https://pubmed.ncbi.nlm.nih.gov/25748050
Autor:
Sun Min Lim, Byoung Chul Cho, Hyo Sup Shim, Hye Ryun Kim, Soo Youl Kim, Joo Hang Kim, Jae Heon Jeong, Kyung Young Chung, Se Kyu Kim, S. M. Bakhtiar Ul Islam, Jae J. Song
Publikováno v:
Journal of Korean Medical Science
Transglutaminase 2 (TG2), a cross-linking enzyme, is involved in drug resistance and in the constitutive activation of nuclear factor kappa B (NF-κB). We investigated the association of non-small cell lung cancer (NSCLC) treatment efficacy with TG2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b764b9bf08d2fb2004f7c2a512ca95
https://doi.org/10.3346/jkms.2013.28.7.1005
https://doi.org/10.3346/jkms.2013.28.7.1005